During methotrexate therapy, should intravenous normal saline with sodium bicarbonate be continued throughout the entire methotrexate course and for an additional 48 hours after the last dose?

Hydration and Alkalinization During High-Dose Methotrexate for PCNSL

Yes, intravenous hydration with sodium bicarbonate should be continued throughout the entire methotrexate infusion and for 48 hours (2 days) after completion of the methotrexate dose to prevent nephrotoxicity and ensure adequate drug clearance.

Rationale and Protocol

The FDA-approved methotrexate label provides explicit guidance for high-dose methotrexate administration 1. Patients must receive 125 mL/m²/hr (3 liters/m²/day) of intravenous hydration during the methotrexate infusion AND for 2 days after the infusion has been completed 1. This hydration regimen should include sodium bicarbonate to maintain urine pH above 7.0 throughout both the methotrexate infusion and leucovorin rescue period 1.

Specific Hydration Protocol

The standard approach includes:

• Pre-hydration: 1,000 mL/m² over 6 hours before starting methotrexate 1
• During and post-infusion: Continue at 125 mL/m²/hr for the duration of methotrexate administration plus 48 hours afterward 1
• Alkalinization: Maintain urine pH >7.0 using sodium bicarbonate (either oral or IV) 1

Why 48 Hours Post-Completion?

Methotrexate is 85% renally excreted and can precipitate in renal tubules at acidic pH, causing acute kidney injury 2. Therapeutic concentrations of methotrexate can persist in CSF for 48 hours after each dose 3. The extended hydration period ensures:

1. Adequate drug clearance: Methotrexate levels must fall below 0.05-0.1 µmol/L before discontinuing supportive care 1, 4
2. Prevention of crystal nephropathy: Alkaline urine (pH >7.0) prevents methotrexate precipitation 1
3. Mitigation of systemic toxicity: Continuous low systemic concentrations can cause myelosuppression, particularly with renal insufficiency or abnormal CSF flow 3

Monitoring Requirements

Critical monitoring includes 1:

• Serum creatinine and methotrexate levels at 24 hours after starting methotrexate
• Daily measurements until methotrexate level <0.05 µmol/L (or <0.1 µmol/L per some protocols 4)
• Urine pH monitoring to ensure maintenance >7.0
• If creatinine increases by 50% or more, or if methotrexate clearance is delayed, continue hydration and alkalinization until levels are safe 1

Common Pitfalls to Avoid

1. Premature discontinuation: Do not stop hydration based solely on time elapsed; methotrexate levels must be documented as safe 1
2. Inadequate alkalinization: Failure to maintain urine pH >7.0 significantly increases nephrotoxicity risk 1, 5, 6
3. Volume overload: While maintaining hydration, monitor for fluid accumulation—patients with pleural effusions or ascites require drainage before methotrexate administration 1
4. Renal impairment: Patients with baseline renal dysfunction require dose reduction and more intensive monitoring 2

Alternative Considerations

Recent studies suggest that raising the methotrexate clearance threshold from <0.05 to <0.1 µmol/L may safely reduce hydration duration by approximately 24 hours 4. However, the FDA label remains the authoritative standard, and deviation should only occur with careful monitoring and institutional protocols 1.

During IV sodium bicarbonate shortages, enteral alkalinization protocols with oral bicarbonate tablets have been used successfully, though they may have higher rates of inadequate alkalinization requiring conversion back to IV therapy 5, 6.